Generic Name

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

GENERIC NAME: MECHANISM OF ACTION: SIDE EFFECTS/ADVERSE NURSING RESPONSIBILITY

REACTION
ranitidine Inhibits histamine action at histamine H2-
receptors of gastric parietal cells. Common side effects: Baseline assessment
Therapeutic Effect: Inhibits gastric acid  Obtain history of epigastric/abdominal pain.
secretion. Reduces gastric volume, hydrogen  headache  Intervention/evaluation
ion concentration.  abdominal pain  Assess mental status in elderly. Question
 agitation present abdominal pain, GI distress.
BRAND NAME: INDICATION:  hair loss Patient/family teaching
 confusion • Smoking decreases effectiveness of medication.
Zantac Prevention of duodenal ulcer.
 constipation
 Do not take medicine within 1 hr of
 diarrhea
magnesium- or aluminum-containing antacids.
 dizziness
• Transient burning/pruritus may occur with IV
DRUG ILLUSTRATION:  hypersensitivity
administration.
reaction
• Report headache.
 nausea
 vomiting • Avoid alcohol, aspirin.
 anemia
 necrotizing
inflammation of the
small intestine and
colon in fetus or
newborn

CLASSIFICATION: CONTRAINDICATION:

Histamine H2-receptor antagonist Hypersensitivity to ranitidine. OTC: Do not


DOSAGE/FREQUENCY/ROUTE use if trouble or pain when swallowing food,
vomiting with blood, or bloody or black stool
2.5 mg IV q8 is present. Do not use 150 mg with kidney
disease (unless medically advised).
Cautions: Renal/hepatic impairment, elderly
pts, history of acute porphyria.

GENERIC NAME: MECHANISM OF ACTION: SIDE EFFECTS/ADVERSE REACTION NURSING RESPONSIBILITY


vancomycin Inhibits cell wall synthesis by binding
to the D-Ala-D-Ala terminal of the
growing peptide chain during cell wall Side effects Baseline assessment
synthesis, resulting in inhibition of the • Frequent: • Avoid other ototoxic, nephrotoxic
transpeptidase, which prevents further PO: Bitter/unpleasant taste, nausea, medications if possible.
elongation and cross-linking of the vomiting, mouth irritation (with oral • Obtain culture, sensitivity test before
peptidoglycan matrix (see glycopeptide solution). giving first dose (therapy may begin
pharm). • Rare: before results are known).
BRAND NAME: INDICATION: Parenteral: Phlebitis, • Consider placement of central venous
thrombophlebitis, pain at peripheral line/PICC line.
Vancocin life threatening infections, sepsis IV site, dizziness, vertigo, tinnitus, Intervention/evaluation
chills, fever, rash, necrosis with • Monitor serum renal function tests,
extravasation. I&O. Assess skin for rash.
DRUG ILLUSTRATION: PO: Rash. • Check hearing acuity, balance.
Adverse effects/toxic reactions • Monitor B/P carefully during infusion.
Monitor for "red man"syndrome.
• Nephrotoxicity (acute kidney injury, • Evaluate IV site for phlebitis (heat,
acute tubular necrosis, renal failure), pain, red streaking over vein).
ototoxicity (temporary or permanent • Obtain vancomycin peak/trough level
hearing loss) may occur. as ordered by physician or pharmacist
• Therapeutic serum level: peak: 20–40
• Too-rapid infusion may cause "red
mcg/mL; trough: 10–20 mcg/mL.
man syndrome," a common adverse
• Toxic serum level: peak: greater than
reaction characterized by pruritus,
40 mcg/mL; trough: greater than 20
urticaria, erythema, angioedema,
mcg/mL.
tachycardia, hypotension, myalgia,
Patient/ family teaching
maculopapular rash (usually appears
• Continue therapy for full length of
on face, neck, upper torso).
CLASSIFICATION: CONTRAINDICATION: treatment.
• Cardiovascular toxicity (cardiac • Doses should be evenly spaced.
Tricyclic glycopeptide antibiotic. Hypersensitivity to vancomycin. depression, arrest) occurs rarely. • Report ringing in ears, hearing loss,
DOSAGE/FREQUENCY/ROUTE Cautions: Renal impairment; Onset usually occurs within 30 min changes in urinary frequency or
concurrent therapy with other ototoxic, of start of infusion, resolves within consistency.
40 mg + 10cc PNSS infuse over 30 nephrotoxic medications, elderly pts, • Lab tests are important part of total
hrs following infusion. May result
mins IV q6 dehydration. from too-rapid rate of infusion. therapy.
References:

Clinical Pathway:

Karen G. (2018). “Imperforate Anus”. Retrieved from https://www.healthline.com/health/imperforate-anus

Belleza M. (2021). “Imperforate Anus”. Retrieved from https://www.healthline.com/health/imperforate-anus

NCP:

Wayne G. (2022). “Impaired Tissue Integrity & Wound Care Nursing Care Plan”. Retrieved from https://nurseslabs.com/impaired-tissue-integrity/

RNlessons. (2022). “Wayne BSN, RN. 2022. “Impaired Tissue Integrity & Wound Care Nursing Care Plan”. Retrieved from https://rnlessons.com/impaired-skin-integrity/

Wagner, M. (2021). “Impaired Skin Integrity Nursing Diagnosis & Care Plan”. Retrieved from https://www.nursetogether.com/impaired-skin-integrity-nursing-diagnosis-care-
plan/

DS:

Kizior Robert J. BS, RPh. & Hodgson, Keith J. RN, BSN, CCRN. Sauders Nursing Drug Handbook 2019. Elsevier
AFT Pharmaceuticals Ltd. Ranitidine Hydrochloride 150 mg/10 mL Syrup data sheet September 2018. Medsafe. http://www.medsafe.govt.nz. Accessed 15/09/2022.

GreenPharmacy (2023). “VANCOMYCIN HCL 1 GM” Retrieved from. https://greenpharmacyonline.com/rx-products/vancomycin-hcl-1-gm.html

Caspian Tamin (2023). “Ranitidine. Retrieved from. https://www.caspiantamin.com/en/product/ranitidine

You might also like